Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

BACKGROUND: Nocturia is a common urinary symptom of multiple sclerosis (MS) which can affect quality of life (QoL) adversely. Melatonin is a hormone known to regulate circadian rhythm and reduce smooth muscle activity such as in the bladder. There is limited evidence supporting use of melatonin to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Drake, Marcus J., Canham, Luke, Cotterill, Nikki, Delgado, Debbie, Homewood, Jenny, Inglis, Kirsty, Johnson, Lyndsey, Kisanga, Mary C., Owen, Denise, White, Paul, Cottrell, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091206/
https://www.ncbi.nlm.nih.gov/pubmed/30081859
http://dx.doi.org/10.1186/s12883-018-1114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091206/
https://www.ncbi.nlm.nih.gov/pubmed/30081859
http://dx.doi.org/10.1186/s12883-018-1114-4

Ejemplares similares